CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in September:
Wells Fargo Healthcare Conference
Location:
Boston, MA
Date: Wednesday, September 6, 2017
Presentation:
10:15 a.m. ET
Speakers: Dr. August Troendle, President & Chief
Executive Officer, and Jesse Geiger, Chief Financial Officer & Chief
Operating Officer, Laboratory Operations
A live webcast of each presentation will be accessible through the “Investors” section of the Company’s website at www.medpace.com and will be available for replay following each event.
About Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its physician-led, high-science, and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,500 people across 35 countries.
